Das Mistelpräparat Iscucin-Herstellung, Analytik, Wirkung in vitro

Zuzak, T.; Rist, L.; Viviani, A.; Pally, Jenny; Mol, C.; Riegert, U.; Meyer, U.

doi:10.14271/DMS-18580-DE

Publication type:	Article in scientific journal
Type of review:	Not specified
Title:	Das Mistelpräparat Iscucin-Herstellung, Analytik, Wirkung in vitro
Authors:	Zuzak, T. Rist, L. Viviani, A. Pally, Jenny Mol, C. Riegert, U. Meyer, U.
DOI:	10.14271/DMS-18580-DE
Published in:	Der Merkurstab - Zeitschrift für anthroposophische Medizin
Volume(Issue):	57
Issue:	6
Page(s):	467
Pages to:	473
Issue Date:	2005
Publisher / Ed. Institution:	Gesellschaft Anthroposophischer Ärzte in Deutschland
ISSN:	0935-798X
Language:	German
Subjects:	Mistletoe; Iscucin
Subject (DDC):	615: Pharmacology and therapeutics
Abstract:	The mistletoe preparate Iscucin was developed from 1957 onwards by the anthroposophical physician Karl Köller (1896-1975). In 1978 the manufacture of the preparation was transferred to the company WALA. Mistletoes from eight different host trees are used, among them poplar, willow and linden. The mistletoe plants together with the haustoria are harvested in summer and winter and then carefully dried. The drugs are extracted, and the extracts from the summer and winter plants are combined in a mixing apparatus constructed by Köller. Subsequently, dilutions are made in vicesimal steps (1:20) and the potencies are labelled with alphabetically consecutive letters, from H (1st dilution step = 5%) to A (10th dilution step). The Iscucins manufactured from deciduous trees are very high in lectins in some cases. In a cytotoxicity test the Iscucin-preparates of strength H show a clear growth suppressing effect on nine tumor cell lines. The inhibition effect is up to 97 %, depending on the mistletoe and the cell line. Especially the lectin-rich Iscucins (Tiliae, Crataegi) seem to be an interesting possibility for intra- and peritumoral use.
URI:	https://digitalcollection.zhaw.ch/handle/11475/9472
Fulltext version:	Published version
License (according to publishing contract):	Licence according to publishing contract
Departement:	Life Sciences and Facility Management
Organisational Unit:	Institute of Chemistry and Biotechnology (ICBT)
Appears in collections:	Publikationen Life Sciences und Facility Management

Files in This Item:

There are no files associated with this item.

Show full item record

Zuzak, T., Rist, L., Viviani, A., Pally, J., Mol, C., Riegert, U., & Meyer, U. (2005). Das Mistelpräparat Iscucin-Herstellung, Analytik, Wirkung in vitro. Der Merkurstab - Zeitschrift für anthroposophische Medizin, 57(6), 467–473. https://doi.org/10.14271/DMS-18580-DE

Zuzak, T. et al. (2005) ‘Das Mistelpräparat Iscucin-Herstellung, Analytik, Wirkung in vitro’, Der Merkurstab - Zeitschrift für anthroposophische Medizin, 57(6), pp. 467–473. Available at: https://doi.org/10.14271/DMS-18580-DE.

T. Zuzak et al., “Das Mistelpräparat Iscucin-Herstellung, Analytik, Wirkung in vitro,” Der Merkurstab - Zeitschrift für anthroposophische Medizin, vol. 57, no. 6, pp. 467–473, 2005, doi: 10.14271/DMS-18580-DE.

ZUZAK, T., L. RIST, A. VIVIANI, Jenny PALLY, C. MOL, U. RIEGERT und U. MEYER, 2005. Das Mistelpräparat Iscucin-Herstellung, Analytik, Wirkung in vitro. Der Merkurstab - Zeitschrift für anthroposophische Medizin. 2005. Bd. 57, Nr. 6, S. 467–473. DOI 10.14271/DMS-18580-DE

Zuzak, T., L. Rist, A. Viviani, Jenny Pally, C. Mol, U. Riegert, and U. Meyer. 2005. “Das Mistelpräparat Iscucin-Herstellung, Analytik, Wirkung in vitro.” Der Merkurstab - Zeitschrift für anthroposophische Medizin 57 (6): 467–73. https://doi.org/10.14271/DMS-18580-DE.

Zuzak, T., et al. “Das Mistelpräparat Iscucin-Herstellung, Analytik, Wirkung in vitro.” Der Merkurstab - Zeitschrift für anthroposophische Medizin, vol. 57, no. 6, 2005, pp. 467–73, https://doi.org/10.14271/DMS-18580-DE.